| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 4.14B | — |
| Operating expense | — | — |
| Net income | -576.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TEVA returned +102.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +19.6% |
| 1 year | +102.3% |
| 5 years | +296.4% |
| 10 years | -22.7% |
| All-time high | $69.02 (Jul 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TEVA would be worth today ›No. Teva Pharmaceutical Industries Limited has not paid a dividend in the past 12 months.
Teva Pharmaceutical Industries Limited stock trades on NYSE under the ticker symbol TEVA.
Teva Pharmaceutical Industries Limited is part of the Healthcare sector.
Teva Pharmaceutical Industries Limited has a market cap of 43.51B USD, based on the latest quote.
Teva Pharmaceutical Industries Limited is scheduled to report earnings on Nov 4, 2026.
